Maninjay Atianand
@atianand_lab
building a NewCo. ex. asst prof @PittTweet | #RNA #microprotein #biotech
I just published my weekly reflections: docs.google.com/document/d/1Gr… . An IDE for your life. Sycosocial. Memetic gain-of-function.The News Feed Betrayal effect. Human computing. The Philosopher-Builder. Synergistic Satisfiers. Polychrome quilt. Chocolate and Peanut Butter…
Insightful essay - worth the time reading this… “AI discourse in science in the context of production-progress paradox.”
Some aspects of AI discourse seem to come from a different planet, oblivious to basic realities on Earth. AI for science is one such area. In this new essay, @sayashk and I argue that visions of accelerating science through AI should be considered unserious if they don't confront…
So, who decides what deserves our attention? interesting thread on issues re scientific content consumption. there is much larger problem - how do you find, assess and consume quality papers?
Social media has truly warped science consumption. On one hand it has massively democratized it. On the other hand, it's become extremely easy to use hype to simply amplify things that are simply not true. 1/
🚨 Just dropped! GREmLN is a graph-based transformer model that uses the molecular logic of cells to enable insights into disease states. This nimble model accounts for causality + locality using gene regulatory networks📄 Read the preprint: bit.ly/44lLF8x
why don’t we have more medicines? inventing medicines has grown less efficient, limited by our knowledge of biological targets for the 1st time, AI & genomics have the potential to make this knowledge abundant – one of the largest potential impacts of the intelligence age.
📢 Call for proposals: Boltz small-molecule design collaboration! 🧬 Can we help design your ideal molecule? Can you help us improve our open-source models? Please reach out or share with scientists you know! More details below! It has been great to see the level of excitement…
One-month update of Biomni⬇️ Excited to see how Biomni has automated 15K+ research tasks for biologists!
🧬 1 month update of Biomni: the general-purpose biomedical AI agent! 🌍 Scientists from 2K+ organizations in 76 countries registered 🤖 15K+ research tasks automated — saving millions of biologists hours 💻 12M+ lines of code written 🔥 3B+ tokens burned 🧬 Spanned across…
congrats Brandon and the Axiom team. Scale of the platform/data is so impressive..
To replace animal testing with AI, we need MASSIVE human datasets. Today, we're thrilled to share Axiom's new data exploration tool, providing the ability to visually explore the world's largest primary human liver toxicity dataset. Built with Axiom's proprietary wetlab…
My family moved to the US when I was 8, but by the time I turned 20, my dad was still on an H1B (waiting to get processed for a green card). Once I turned 21, I would age out as his dependent, despite the fact that I basically grew up in the US. I thought I'd have to become a…
SO PROUD of the @CityTx_ forming their 2nd major alliance!!!! This time with @Biogen for a CNS target, w/ $46M upfront and >$1B in total deal value! Combined with earlier @BauschLomb deal, City is growing strong in a tough tape! globenewswire.com/news-release/2…
BIG NEWS! Ashlee Vance just profiled the first parents with not one — but two— Orchid superbabies. This is just the beginning. Every child, genetically blessed from day one.
New Core Memory episode on the future of babies
wow. this is so good and funny - watch till the end.
I used to shoot $500k pharmaceutical commercials. I made this for $500 in Veo 3 credits in less than a day. What’s the argument for spending $500K now? (Steal my prompt below 👇🏼)
The NIH is broken. Much of $50 billion a year funds bureaucracy, political nonsense, and academic welfare instead of breakthrough science. America needs to slash the red tape, fund bold ideas, and stop rewarding mediocrity if we want to lead the next golden age of science. 🧵
in ~15 years, metastatic melanoma went from a disease with a median 6 month survival time to one where 52% of patients have melanoma-specific survival 10 years out may we all get a chance to work on medical technologies like this - my god! nejm.org/doi/full/10.10…
More of this 👇 Great initiative by @Lux_Capital
1/ We're dedicating $100M to support American scientists facing funding cuts through the Lux Science Helpline, an expansion of our Lux Labs program. To compete in the future, innovation must be funded 🧪💡
🚀 We're thrilled to announce that #HAYATherapeutics have successfully raised $65Million in #SeriesA round of financing 🎉 A huge #THANKYOU to our TEAM, PARTNERS, and INVESTORS! 🙌 ➡️hayatx.com/news @SofinnovaVC @EarlybirdVC
Great to see this finally happen. No excuse to pay those ridiculous "gold open access" highway robbery glam journal fees any more, at least for NIH funded research. Everything on preprint servers & PMC for free for everyone.
NIH Director Dr. Jay Bhattacharya has announced that the NIH Public Access Policy, originally slated to go into effect on 12/31/25 will now be effective 7/1/25. Read more in his statement: bit.ly/4jTQI4O